Finally, this mechanism is also a relevant feature of anti-tumor immune responses, as the presence of tumor antigen peptides associated with MHC complexes in EVs released from cancer cells has been shown to elicit a specific cytotoxic T lymphocyte response [38]. This evidence concerns the gene HLA-C and neoplasm.